WX390
Drug timelines are a Plus or Pro feature.
5 regulatory and trial events tracked for WX390, covering 2023-11-15 to 2026-02-06. Get the full timeline:
Most recent: Clinical Trial Update: A Phase III Clinical Study of WX390 Combined With Toripalimab Versus Investigator's Choice of Therapy in Patients With Recurrent or Metastatic Cervical Cancer Who Have Failed Prior Platinum-Based Treatment [Phase 3]